Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17
- PMID: 19255062
- PMCID: PMC2675651
- DOI: 10.1093/carcin/bgp054
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17
Abstract
Sex hormones influence the susceptibility of inbred mice to liver cancer. C57BR/cdJ (BR) females are extremely susceptible to spontaneous and chemically induced liver tumors, in part due to a lack of protection against hepatocarcinogenesis normally offered by ovarian hormones. BR males are also moderately susceptible, and the susceptibility of both sexes of BR mice to liver tumors induced with N,N-diethylnitrosamine relative to the resistant C57BL/6J (B6) strain is caused by two loci designated Hcf1 and Hcf2 (hepatocarcinogenesis in females) located on chromosomes 17 and 1, respectively. The Hcf1 locus on chromosome 17 is the predominant modifier of liver cancer in BR mice. To validate the existence of this locus and investigate its potential interaction with Hcf2, congenic mice for each region were generated. Homozygosity for the B6.BR(D17Mit164-D17Mit2) region resulted in a 4-fold increase in liver tumor multiplicity in females and a 4.5-fold increase in males compared with B6 controls. A series of 16 recombinants covering the entire congenic region was developed to further narrow the area containing Hcf1. Susceptible heterozygous recombinants demonstrated a 3- to 7-fold effect in females and a 1.5- to 2-fold effect in males compared with B6 siblings. The effect in susceptible lines completely recapitulated the susceptibility of heterozygous full-length chromosome 17 congenics and furthermore narrowed the location of the Hcf1 locus to a single region of the chromosome from 30.05 to 35.83 Mb.
Figures


Similar articles
-
Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5848-53. doi: 10.1073/pnas.93.12.5848. Proc Natl Acad Sci U S A. 1996. PMID: 8650181 Free PMC article.
-
C57BR/cdJ hepatocarcinogen susceptibility genes act cell-autonomously in C57BR/cdJ<-->C57BL/6J chimeras.Cancer Res. 2003 Aug 15;63(16):4914-9. Cancer Res. 2003. PMID: 12941815
-
The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility.Carcinogenesis. 2001 Nov;22(11):1853-62. doi: 10.1093/carcin/22.11.1853. Carcinogenesis. 2001. PMID: 11698349
-
Genetic and hormonal regulation of murine hepatocarcinogenesis.Prog Exp Tumor Res. 1999;35:131-42. doi: 10.1159/000062009. Prog Exp Tumor Res. 1999. PMID: 10377757 Review. No abstract available.
-
Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.Biochim Biophys Acta. 2006 Apr;1765(2):126-47. doi: 10.1016/j.bbcan.2005.08.007. Epub 2005 Sep 15. Biochim Biophys Acta. 2006. PMID: 16216419 Review.
Cited by
-
Mouse models for liver cancer.Mol Oncol. 2013 Apr;7(2):206-23. doi: 10.1016/j.molonc.2013.01.005. Epub 2013 Feb 5. Mol Oncol. 2013. PMID: 23428636 Free PMC article. Review.
-
Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis.Mol Carcinog. 2015 Oct;54(10):959-70. doi: 10.1002/mc.22165. Epub 2014 May 17. Mol Carcinog. 2015. PMID: 24838184 Free PMC article.
-
Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression.Cancers (Basel). 2021 May 13;13(10):2355. doi: 10.3390/cancers13102355. Cancers (Basel). 2021. PMID: 34068249 Free PMC article.
-
The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis.Carcinogenesis. 2011 Aug;32(8):1162-6. doi: 10.1093/carcin/bgr094. Epub 2011 May 23. Carcinogenesis. 2011. PMID: 21606321 Free PMC article.
References
-
- Parkin DM, et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005;55:74–108. - PubMed
-
- Tanaka K, et al. Serum testosterone: estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res. 2000;60:5106–5110. - PubMed
-
- Yu MW, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J. Natl Cancer Inst. 2001;93:1644–1651. - PubMed
-
- Moradpour D, et al. Pathogenesis of hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 2005;17:477–483. - PubMed
-
- Smith GS, et al. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J. Natl Cancer Inst. 1973;50:1195–1213. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous